The number of FDA warning letters to firms manufacturing and marketing dietary supplements has increased by more than 30 to 81 during the year the agency began assigning Office of Regulatory Affairs inspectors to certain facilities based on their areas of expertise.
The "program alignment" ORA has implemented in 2017 sends inspectors more knowledgeable about FDA's supplement good manufacturing practices regulations, Part 111 of the agency's regulations in CFR 21, to plants,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?